{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:17:55Z","timestamp":1792804675891,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1R21CA185236-01"],"award-info":[{"award-number":["1R21CA185236-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007231","name":"Cornell University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007231","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Weill Cornell Medical College Seed Grant Program"},{"name":"Cornell University's Engineering Learning Initiative Grant"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.biomaterials.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T11:32:40Z","timestamp":1442057560000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells"],"prefix":"10.1016","volume":"73","author":[{"given":"Ye F.","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haelee","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Roman-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari M.","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Cerchietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2015.09.007_bib1","doi-asserted-by":"crossref","first-page":"e18436","DOI":"10.1371\/journal.pone.0018436","article-title":"Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas","volume":"6","author":"Cerchietti","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biomaterials.2015.09.007_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ccr.2009.12.050","article-title":"A\u00a0small-molecule inhibitor of BCL6 kills DLBCL cells in\u00a0vitro and in\u00a0vivo","volume":"17","author":"Cerchietti","year":"2010","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.biomaterials.2015.09.007_bib3","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1172\/JCI42869","article-title":"BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy","volume":"120","author":"Cerchietti","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"issue":"12","key":"10.1016\/j.biomaterials.2015.09.007_bib4","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.2059","article-title":"A\u00a0purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas","volume":"15","author":"Cerchietti","year":"2009","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2015.09.007_bib5","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/0008-5472.CAN-07-5817","article-title":"Sequential transcription factor targeting for diffuse large B-cell lymphomas","volume":"68","author":"Cerchietti","year":"2008","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2015.09.007_bib6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nm1134","article-title":"Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells","volume":"10","author":"Polo","year":"2004","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2015.09.007_bib7","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0611399104","article-title":"Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas","volume":"104","author":"Polo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biomaterials.2015.09.007_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood.V84.3.866.866","article-title":"Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma","volume":"84","author":"Inghirami","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biomaterials.2015.09.007_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.2010.08326.x","article-title":"Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21","volume":"151","author":"Scandurra","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.biomaterials.2015.09.007_bib10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.183.3.971","article-title":"Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2","volume":"183","author":"Martinez-Valdez","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"issue":"8","key":"10.1016\/j.biomaterials.2015.09.007_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biomaterials.2015.09.007_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood-2014-07-587337","article-title":"Integrin alphavbeta3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells","volume":"125","author":"Cayrol","year":"2015","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2015.09.007_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/10428190009060320","article-title":"Integrin-mediated drug resistance in multiple myeloma","volume":"38","author":"Damiano","year":"2000","journal-title":"Leuk. Lymphoma"},{"issue":"21","key":"10.1016\/j.biomaterials.2015.09.007_bib14","doi-asserted-by":"crossref","first-page":"17065","DOI":"10.1074\/jbc.M112.349365","article-title":"alpha2beta1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK)","volume":"287","author":"Naci","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"issue":"22","key":"10.1016\/j.biomaterials.2015.09.007_bib15","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"22","key":"10.1016\/j.biomaterials.2015.09.007_bib16","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMe0808409","article-title":"Microenvironmental protection in diffuse large-B-cell lymphoma","volume":"359","author":"Eng","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"49","key":"10.1016\/j.biomaterials.2015.09.007_bib17","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1038\/onc.2011.195","article-title":"ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma","volume":"30","author":"Singh","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biomaterials.2015.09.007_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajpath.2013.09.018","article-title":"Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma","volume":"184","author":"Gravelle","year":"2014","journal-title":"Am. J. pathol."},{"key":"10.1016\/j.biomaterials.2015.09.007_bib19","first-page":"362326","article-title":"Cancer tissue engineering: a novel 3D polystyrene scaffold for in\u00a0vitro isolation and amplification of lymphoma cancer cells from heterogeneous cell mixtures","volume":"2011","author":"Caicedo-Carvajal","year":"2011","journal-title":"J.\u00a0Tissue Eng."},{"issue":"1","key":"10.1016\/j.biomaterials.2015.09.007_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.137.1.231","article-title":"Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in\u00a0vivo by integrin blocking antibodies","volume":"137","author":"Weaver","year":"1997","journal-title":"J.\u00a0Cell Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2015.09.007_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1535-6108(02)00125-3","article-title":"beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium","volume":"2","author":"Weaver","year":"2002","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2015.09.007_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth1015","article-title":"Three-dimensional culture models of normal and malignant breast epithelial cells","volume":"4","author":"Lee","year":"2007","journal-title":"Nat. Methods"},{"issue":"9","key":"10.1016\/j.biomaterials.2015.09.007_bib23","first-page":"4200","article-title":"Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures","volume":"45","author":"Miller","year":"1985","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.biomaterials.2015.09.007_bib24","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1007\/s00018-011-0763-x","article-title":"Matrix metalloproteinases in tumorigenesis: an evolving paradigm","volume":"68","author":"Hua","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2015.09.007_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10585-008-9209-8","article-title":"Three-dimensional context regulation of metastasis","volume":"26","author":"Erler","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"issue":"3","key":"10.1016\/j.biomaterials.2015.09.007_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nmat4157","article-title":"Light-triggered in\u00a0vivo activation of adhesive peptides regulates cell adhesion, inflammation and vascularization of biomaterials","volume":"14","author":"Lee","year":"2015","journal-title":"Nat. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2015.09.007_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2011.06.008","article-title":"An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma","volume":"155","author":"Singh","year":"2011","journal-title":"J.\u00a0Control. release official J. Control. Release Soc."},{"key":"10.1016\/j.biomaterials.2015.09.007_bib28","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/j.biomaterials.2009.06.001","article-title":"In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells","volume":"30","author":"Singh","year":"2009","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biomaterials.2015.09.007_bib29","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/mt.2008.206","article-title":"Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells","volume":"16","author":"Singh","year":"2008","journal-title":"Mol. Ther."},{"issue":"Pt 14","key":"10.1016\/j.biomaterials.2015.09.007_bib30","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1242\/jcs.017905","article-title":"Regulation of integrin activation through the B-cell receptor","volume":"121","author":"Arana","year":"2008","journal-title":"J.\u00a0Cell Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2015.09.007_bib31","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2009-12-257030","article-title":"EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth","volume":"116","author":"Bouchard","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biomaterials.2015.09.007_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0609.2008.01113.x","article-title":"Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma","volume":"81","author":"Pennanen","year":"2008","journal-title":"Eur. J. Haematol."},{"issue":"7","key":"10.1016\/j.biomaterials.2015.09.007_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/08880010802313657","article-title":"Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma","volume":"25","author":"Bozkurt","year":"2008","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2015.09.007_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1471-2407-7-229","article-title":"The enhanced expression of the matrix metalloproteinase 9 in nasal NK\/T-cell lymphoma","volume":"7","author":"Sakata","year":"2007","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2015.09.007_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/cncr.11905","article-title":"Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma","volume":"100","author":"Sakata","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2015.09.007_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2567.2008.02872.x","article-title":"B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells","volume":"125","author":"Saito","year":"2008","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.biomaterials.2015.09.007_bib37","doi-asserted-by":"crossref","first-page":"e16596","DOI":"10.1371\/journal.pone.0016596","article-title":"Antibodies against CD20 or B-cell receptor induce similar transcription patterns in human lymphoma cell lines","volume":"6","author":"Franke","year":"2011","journal-title":"PLoS One"},{"issue":"7277","key":"10.1016\/j.biomaterials.2015.09.007_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biomaterials.2015.09.007_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrd3937","article-title":"Targeting pathological B cell receptor signalling in lymphoid malignancies","volume":"12","author":"Young","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biomaterials.2015.09.007_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era","volume":"11","author":"Roschewski","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.biomaterials.2015.09.007_bib41","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1182\/blood-2011-02-333773","article-title":"SYK inhibition and response prediction in diffuse large B-cell lymphoma","volume":"118","author":"Cheng","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biomaterials.2015.09.007_bib42","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/blood-2007-07-100115","article-title":"SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.biomaterials.2015.09.007_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"issue":"7323","key":"10.1016\/j.biomaterials.2015.09.007_bib44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nature09621","article-title":"Nanoscale architecture of integrin-based cell adhesions","volume":"468","author":"Kanchanawong","year":"2010","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biomaterials.2015.09.007_bib45","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nri1646","article-title":"Intracellular signalling controlling integrin activation in lymphocytes","volume":"5","author":"Kinashi","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"5642","key":"10.1016\/j.biomaterials.2015.09.007_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.1086652","article-title":"Talin binding to integrin beta tails: a final common step in integrin activation","volume":"302","author":"Tadokoro","year":"2003","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biomaterials.2015.09.007_bib47","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.4049\/jimmunol.1400090","article-title":"Integrin-mediated interactions between B cells and follicular dendritic cells influence germinal center B cell fitness","volume":"192","author":"Wang","year":"2014","journal-title":"J.\u00a0Immunol."},{"issue":"21","key":"10.1016\/j.biomaterials.2015.09.007_bib48","first-page":"5110","article-title":"Nanopatterning reveals an ECM area threshold for focal adhesion assembly and force transmission that is regulated by integrin activation and cytoskeleton tension","volume":"125","author":"Coyer","year":"2012","journal-title":"J.\u00a0Cell Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2015.09.007_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","article-title":"Role of integrins in cell invasion and migration","volume":"2","author":"Hood","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.biomaterials.2015.09.007_bib50","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0301-472X(01)00674-9","article-title":"alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells","volume":"29","author":"Vacca","year":"2001","journal-title":"Exp. Hematol."},{"issue":"13","key":"10.1016\/j.biomaterials.2015.09.007_bib51","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1016\/j.biomaterials.2010.01.058","article-title":"Bioactive hydrogels made from step-growth derived PEG-peptide macromers","volume":"31","author":"Miller","year":"2010","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biomaterials.2015.09.007_bib52","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1021\/bm061191m","article-title":"Rapidly in situ-forming degradable hydrogels from dextran thiols through Michael addition","volume":"8","author":"Hiemstra","year":"2007","journal-title":"Biomacromolecules"},{"issue":"9","key":"10.1016\/j.biomaterials.2015.09.007_bib53","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/anie.200903924","article-title":"Thiol-ene click chemistry","volume":"49","author":"Hoyle","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.biomaterials.2015.09.007_bib54","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1039\/b901979k","article-title":"Thiol-click chemistry: a multifaceted toolbox for small molecule and polymer synthesis","volume":"39","author":"Hoyle","year":"2010","journal-title":"Chem. Soc. Rev."},{"issue":"21","key":"10.1016\/j.biomaterials.2015.09.007_bib55","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1016\/j.biomaterials.2013.03.086","article-title":"The influence of matrix properties on growth and morphogenesis of human pancreatic ductal epithelial cells in 3D","volume":"34","author":"Raza","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2015.09.007_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/adma.201103574","article-title":"Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery","volume":"24","author":"Phelps","year":"2012","journal-title":"Adv. Mater"},{"issue":"19","key":"10.1016\/j.biomaterials.2015.09.007_bib57","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.biomaterials.2013.03.012","article-title":"Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes","volume":"34","author":"Phelps","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2015.09.007_bib58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12195-014-0353-8","article-title":"Microscale Bioadhesive Hydrogel Arrays for Cell Engineering Applications","volume":"7","author":"Patel","year":"2014","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.biomaterials.2015.09.007_bib59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.matbio.2013.10.011","article-title":"Signalling pathways linking integrins with cell cycle progression","volume":"34","author":"Moreno-Layseca","year":"2014","journal-title":"Matrix Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2015.09.007_bib60","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10555-005-5130-7","article-title":"Integrin-dependent signal transduction regulating cyclin D1 expression and G1 phase cell cycle progression","volume":"24","author":"Walker","year":"2005","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.biomaterials.2015.09.007_bib61","first-page":"377","article-title":"Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat","volume":"1","author":"Duvic","year":"2007","journal-title":"Biol. Targets & Ther."},{"issue":"24","key":"10.1016\/j.biomaterials.2015.09.007_bib62","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1182\/blood-2010-05-284414","article-title":"Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists","volume":"116","author":"Mandawat","year":"2010","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.biomaterials.2015.09.007_bib63","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2013-01-481325","article-title":"PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma","volume":"122","author":"Richardson","year":"2013","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.biomaterials.2015.09.007_bib64","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood-2014-11-568923","article-title":"Treatment options for relapsed and refractory multiple myeloma","volume":"125","author":"Nooka","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biomaterials.2015.09.007_bib65","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1084\/jem.20011866","article-title":"The B cell antigen receptor controls integrin activity through Btk and PLCgamma2","volume":"198","author":"Spaargaren","year":"2003","journal-title":"J.\u00a0Exp. Med."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215007528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961215007528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:11:36Z","timestamp":1758903096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961215007528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":65,"alternative-id":["S0142961215007528"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.09.007","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}